Shanghai Shen Lian Biomedical Corporation (SHA:688098)

SHA:688098 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	-	122	146.21	44.98	52.74	44.21
Trading Asset Securities	-	32.82	43.81	162.38	305.12	424.08
Cash & Short-Term Investments	65.59	154.82	190.02	207.35	357.87	468.29
Cash Growth	-51.29%	-18.52%	-8.36%	-42.06%	-23.58%	-20.23%
Accounts Receivable	-	282.11	261.4	273.97	222.76	154.61
Other Receivables	-	3.33	3.17	3.09	6.82	5.99
Receivables	-	285.44	264.57	277.06	229.57	160.61
Inventory	-	94.47	95.1	111.79	115.33	103.42
Other Current Assets	-	1.17	1.14	2.09	2.74	1.14
Total Current Assets	-	535.9	550.83	598.29	705.5	733.46
Property, Plant & Equipment	-	799.83	811.19	823.31	776.66	768.55
Long-Term Investments	-	26.46	6.58	1.59	1.58	1.57
Other Intangible Assets	-	124.7	102.66	93.6	53.12	32.66
Long-Term Deferred Tax Assets	-	14.47	13.26	5.14	6.5	7.08
Long-Term Deferred Charges	-	15.4	33.18	42.35	42.17	35.52
Other Long-Term Assets	-	25.62	36.41	29.72	19.56	19.62
Total Assets	-	1,542	1,554	1,594	1,605	1,598

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	-	16.43	5.44	5.14	8.86	11.33
Accrued Expenses	-	57.56	57.82	42.8	48.37	58.72
Short-Term Debt	-	12.89	14.01	-	-	-
Current Portion of Leases	-	0.37	0.48	0.33	0.14	0.13
Current Income Taxes Payable	-	0	-	0.23	7.58	5.09
Current Unearned Revenue	-	25.01	19.59	6.65	10.61	8.92
Other Current Liabilities	-	21.07	18.86	21.35	21.66	29.33
Total Current Liabilities	-	133.33	116.2	76.5	97.22	113.53
Long-Term Leases	-	0.92	1.01	0.92	0.31	0.38
Long-Term Unearned Revenue	-	9.11	11.08	9.49	10.36	11.3
Long-Term Deferred Tax Liabilities	-	0.06	0.21	0.02	0.32	0.27
Total Liabilities	-	143.41	128.5	86.93	108.21	125.48

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	-	410.64	410.64	410.64	410.64	410.64
Additional Paid-In Capital	-	539.23	539.23	539.23	546.04	552.18
Retained Earnings	-	459.25	479.74	538.85	540.19	516.05
Treasury Stock	-	-20	-18.32	-	-	-
Total Common Equity	1,387	1,389	1,411	1,489	1,497	1,479
Minority Interest	-	9.85	14.33	18.34	-	-5.89
Shareholders' Equity	1,395	1,399	1,426	1,507	1,497	1,473
Total Liabilities & Equity	-	1,542	1,554	1,594	1,605	1,598

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	53.45	14.17	15.49	1.25	0.45	0.51
Net Cash (Debt)	12.14	140.65	174.53	206.1	357.42	467.78
Net Cash Growth	-89.84%	-19.41%	-15.32%	-42.34%	-23.59%	-20.32%
Net Cash Per Share	0.04	0.34	0.43	0.52	0.88	1.15
Filing Date Shares Outstanding	293.58	407.23	407.53	410.64	410.64	379.56
Total Common Shares Outstanding	293.58	407.23	407.53	410.64	410.64	379.56
Working Capital	-	402.57	434.63	521.79	608.29	619.93
Book Value Per Share	3.38	3.41	3.46	3.63	3.65	3.90
Tangible Book Value	1,264	1,264	1,309	1,395	1,444	1,446
Tangible Book Value Per Share	3.08	3.10	3.21	3.40	3.52	3.81
Buildings	-	363.63	343.74	318.94	298.9	285.68
Machinery	-	714.47	600.61	595.91	577.97	495.93
Construction In Progress	-	95.06	177.87	163.44	98.95	133.78

Data Source: S&P Global Market Intelligence Last updated: Oct 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 5, 2026

Data Sources Report a data error